Nuzzo, Silvia (2018) Selection of aptamers targeting a hypoxia marker: Carbonic Anhydrase-IX (CA-IX). [Tesi di dottorato]

Preview	Text Silvia_Nuzzo_XXX_ciclo_Doctorate_in_Molecular_Medicine_and_Medical_Biotechnology_short_version.pdf Download (932kB) | Preview
Preview	Text Silvia_Nuzzo_XXX_ciclo_Doctorate_in_Molecular_Medicine_and_Medical_Biotechnology_long_version_.pdf Download (2MB) | Preview

[error in script] [error in script]

Item Type:	Tesi di dottorato
Resource language:	English
Title:	Selection of aptamers targeting a hypoxia marker: Carbonic Anhydrase-IX (CA-IX)
Creators:	Creators Email Nuzzo, Silvia nuzzo.silvia@gmail.com
Date:	2018
Number of Pages:	94
Institution:	Università degli Studi di Napoli Federico II
Department:	dep14
Dottorato:	phd054
Ciclo di dottorato:	30
Coordinatore del Corso di dottorato:	nome email Avvedimento, Vittorio Enrico vittorioenrico.avvedimento@unina.it
Tutor:	nome email de Franciscis, Vittorio UNSPECIFIED
Date:	2018
Number of Pages:	94
Keywords:	aptamers, hypoxia
Settori scientifico-disciplinari del MIUR:	Area 06 - Scienze mediche > MED/04 - Patologia generale
Date Deposited:	27 Dec 2017 23:52
Last Modified:	25 Jul 2020 01:00
URI:	http://www.fedoa.unina.it/id/eprint/12248

Collection description

Aptamers are selected by an in vitro combinatorial chemistry approach, named Systematic Evolution of Ligands by Exponential enrichment (SELEX), and they are able to bind with high affinity and specificity virtually any given molecule. Compared to monoclonal antibodies, they have a small size that results in their rapid tumour penetration; they are not immunogenic and could be easily modified to increase their in vivo stability. Thus, in this study we describe the selection of RNA-based aptamers directed against an hypoxic biomarker. Firstly, we performed two different cell-based SELEX protocols that allowed the specific enrichment for the target. Furthermore, we characterized and improved the two best sequences selected, named S-47s1 and S-51s1, that we are still studying to handle a final product usable for diagnostic and therapeutic purposes.

Downloads

Actions (login required)

View Item